## Abstract ## BACKGROUND. Concerns remain about risk of cancer after radioactive iodine (RAI) treatment for hyperthyroidism, especially in organs that concentrate iodine. The objective was to assess the longβterm cancer risk from RAI treatment for hyperthyroidism. ## METHODS. A total of 2793 hy
Increased cancer incidence after radioiodine treatment for hyperthyroidism
β Scribed by Luca Giovanella
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 35 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Increased Cancer Incidence After Radioiodine Treatment for Hyperthyroidism M etso et al. 1,2 recently reported increased cancer mortality in hyperthyroid patients treated by radioiodine. Major limitations of those works, as lacking of hyperthyroid controls, were correctly discussed by the authors. However, in our opinion the evaluation of administered activity and associated mortality risk should be biased. In fact, the analysis was performed on 3 subgroups (ie, patients treated by 55-258 MBq, 259-369 MBq, and 370-2664 MBq, respectively) and increased mortality was observed only in the latter. Because 1) mean administered activity was 305 MBq, 2) only 24% of patients received more than 370 MBq, and 3) the 370-2664 MBq is a very wide range, more detailed analysis of the activity received by patients who died after radioiodine is needed. In fact, activities more than 600-740 MBq are not usually administered to treat hyperthyroidism and Metso et al.
π SIMILAR VOLUMES
Increased Cancer Incidence After Radioiodine Treatment for Hyperthyroidism M etso et al. 1,2 recently reported increased cancer mortality in hyperthyroid patients treated by radioiodine. Major limitations of those works, as lacking of hyperthyroid controls, were correctly discussed by the authors. H
## Abstract We reviewed the courses of patients treated during childhood or adolescence for thyroid cancer to estimate the frequency of, and to identify possible risk factors for, the occurrence of second malignant tumors in this population. We identified all patients treated for thyroid cancer in
Cancer mortality was studied in 10,552 Swedish hyperthyroid patients treated with '"1 between 1950 and 1975. The patients were matched with the Swedish Cause-of-Death Register and the cases of 977 patients who died from cancer or leukemia were studied. The patients had been followed up for an averag